通过表观遗传抑制β2-微型球蛋白超强增强剂来降低中介细胞 stromal 细胞上人类白细胞抗原的下调
Fei Wang1,2, Ran Li3, Jing Yi Xu2
1Department of Sports Medicine of the Second Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
Nature biomedical engineering
|October 21, 2024
概括
向介质细胞 (MSCs) 中的特定基因增强剂可以减少细胞疗法中的免疫排斥. 这种表观遗传编辑策略改善了细胞存活率和治疗效果,为通用细胞来源铺平了道路.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 全基细胞疗法因人白细胞抗原 (HLA) 不匹配而面临免疫排斥.
- 目前用于制造免疫兼容细胞的方法可能会导致基因组不稳定性或细胞毒性.
研究的目的:
- 研究β2-微球蛋白超增强剂 (B2M-SE) 在调节HLA类I (HLA-I) 表达在介质细胞 stromal 细胞 (MSCs) 上的作用.
- 开发一种新的表观遗传策略,用于生成与免疫相容的MSCs,用于全原细胞疗法.
主要方法:
- 在MSC中针对B2M-SE的向表观遗传抑制.
- 评估HLA-I的表面表达.
- 评估T细胞激活和自然杀手 (NK) 细胞细胞毒性.
- 在LPS诱导的急性肺损伤的人性化小鼠模型中测试了经过表观遗传编辑的MSC.
主要成果:
- 对B2M-SE的表观遗传抑制显著降低了MSCs的表面HLA-I表达.
- 降低的HLA-I水平低于异性T细胞激活的值,但足以逃避NK细胞.
- 经过表观遗传编辑的MSC在急性肺损伤模型中显示出更好的生存率和更强的治疗疗效.
结论:
- 针对B2M-SE的表观遗传抑制是一种可行的策略,可以产生免疫相容的MSC.
- 这种方法可以在全源细胞疗法中克服与HLA相关的免疫排斥.
- 这些发现支持开发"现成"细胞来源,用于更广泛的治疗应用.
相关概念视频
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K